We are a company that researches and develops autoimmune cell therapy products using NK immune cells. It is a Korean biotechnology company that possesses NK cell culture technology, which is essential for the treatment of various cancers and autoimmune diseases.
Immune cell therapy is one of the most active drugs in the biotechnology market. It is a next-generation anticancer drug and autoimmune disease drug, and its growth potential is endless. Especially, NK cells in immune cells have excellent ability to treat diseases, but bio-industry's judgment is that it is not easy to develop effective therapeutic agents due to difficulties in cell culture and activation.
In this situation, we have developed and possessed the technology of mass culture of NK cells. Especially, we have the ability to activate NK cells and have the ability and value in the immune cell therapeutic market.
We are trying to carry out technology transfer and treatment business with the countries around the world for the treatment of suffering patients not only in Korea but also all over the world. We do this because we are a company with a corporate philosophy to provide equal opportunities to all patients around the world. In addition, part of the company's profits will be used for free treatment of disadvantaged patients such as pediatric cancer patients and boys and girls, and will become a corporation that contributes to humanity.
We are expecting the remarkable growth and development of the immune cell therapy market in the world using the technology of our company in the current situation that development of the immune cell therapeutic drug market is expected to progress rapidly. We also hope that our technology will help patients around the world recover happiness and laughter. Thank you.